Posters

C3F8 injection in Descemet’s membrane detachment following uncomplicated phacoemulsification

Poster Details

First Author: R.Altan-Yaycioglu TURKEY

Co Author(s):                  

Abstract Details

Purpose:

To present a case with Descemet’s membrane detachment following uncomplicated phacoemulsification surgery and discuss the treatment in the late postoperative weeks.

Setting:

Baskent University, Faculty of Medicine, Department of Ophthalmology, Adana

Methods:

A 74-year-old male patient presented to our clinic with decreased visual acuity in the right eye. He has been following with the diagnosis of blepharitis and dry eye, and had a history of phacoemulsitification in the left eye three years earlier. Ophthalmic examination revealed visual acuity of 20/10 in the right and 20/40 in the left eye. Biomicroscobic exam revealed bilateral blepharitis, central corneal opacity, nuclear cataract in the right and PCIOL in the left eye. Intraocular pressure was 12 mmHg bilaterally. Fundoscopy showed retinal pigment epithelial changes in macula. The patient underwent uncomplicated phacoemulsification and PCIOL implantation.

Results:

At postoperative day 1 visual acuity was hand motion, and cornea had diffuse edema. With topical treatment of steroids and artificial tears the edeme resolved in peripheral cornea and remained edematous in the central cornea in the following 2.5 months. Corneal pachymetry was 764 μm. Optical coherence tomography showed Descemet’s membrane detachment. Intracameral C3F8 was injected. In the following days Descemet’s membrane reattached and corneal edema resolved. The pachymetry at 4th day was 547 μm. The intracameral air, although decreased in size, remained in anterior chamber for almost one month. The visual acuity increased to 20/40.

Conclusions:

Following uneventful phacoemulsification, when corneal edema is refractory to treatment, Descemet’s membrane detachment should be remembered in patients with corneal opacity. In those patients, C3F8 injection is a viable option even in the late postoperative weeks. FINANCIAL DISCLOUSRE: NONE